Antisense and RNAi Therapeutics Market Accelerates as Precision Medicine, Gene Silencing Innovation
Key Highlights Antisense and RNAi Therapeutics Market valued at USD 6.46 billion in 2025. Market projected to reach USD 23.65 billion by 2034 at a 15.5% CAGR. Precision medicine and gene silencing technologies continue driving market expansion. North America leads global revenue through biotechnology … Read more